Estimation of Tadalafil in Tablet Dosage form by UV Spectrophotometric Method

 

Mayur S. Jain*, Shashikant D. Barhate

Shree Sureshdada Jain Institute of Pharmaceutical Education and Research, Jammer, (MH)

*Corresponding Author E-mail: mayurjain176@gmail.com

 

ABSTRACT:

For the measurement of tadalafil in tablet formulation, two straight forward, affordable, accurate, and exact UV and first derivative spectrophotometric techniques have been devised. Tadalafil exhibits zero crossover at 284nm in the first order derivative spectra (Method-B) and an absorbance peak at 284nm (Method-A). With these two techniques, Beer's law is followed in the concentration range of 20–120 micrograms/mL. The analysis's findings were statistically confirmed, and the recovery studies were deemed adequate. Their conclusions were unaffected by the prevalent excipients and additives.

 

KEYWORDS: Tadalafil, UV Spectrophotometry, First order derivative spectroscopy, Methanol.

 

 


INTRODUCTION:

The crystalline powder of tadalafil is white to off-white in color. It dissolves somewhat in methanol and somewhat in water. Tadalafil's chemical formula is C22H19N3O4, and its molecular weight is 438.4 g/mol. After oral treatment, tadalafil is quickly absorbed. It takes 30 to 120 minutes to attain the maximal plasma concentration. The cytochrome P450 enzyme system breaks down tadalafil in the liver. 17.5 hours is the elimination half-life. One PDE5 inhibitor is tadalafil. One of the enzymes that breaks down cGMP is PDE5. One chemical that is involved in erectile function is called cGMP. Tadalafil aids in boosting cGMP levels in the penis, which causes an erection, by preventing the breakdown of cGMP.

 

Table No 1: Drug Profile for Tadalafil

Drug Name

Tadalafil

Brand Name

Cialis

Class

Phosphodiesterase type 5 (PDE5) inhibitor

Indications

Erectile dysfunction, benign prostatic hyperplasia (BPH)

Dosage

2.5-20mg orally once daily

Contraindications

Heart disease, liver disease, kidney disease, nitrate

Medications

Precautions

Use with caution in people with diabetes, high blood pressure, and bleeding disorders

Overdose

Symptoms may include headache, flushing, and upset stomach. Seek medical attention if you experience any of these symptoms.

Storage

Store at room temperature in a dry place

Structure

 

IUPAC

(2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione. 

 

UV and first order derivative spectroscopy provide greater selectivity than common spectroscopy and offer powerful approaches for resolution of band overlapping. The aim of the present study is the development of simple, accurate and sensitive UV and first derivative spectroscopic methods for the determination of Tadalafil.

 

INSTRUMENTATION:

Using a Double beam Shimadzu UV/Visible spectrophotometer, spectroscopic analysis was performed. In quartz cuvettes with a 1cm matched cell, zero order absorption spectra were obtained spanning the 200–400 nm wavelength range against a solvent blank. The first order derivative spectra across the 200–400nm range were acquired for every solution. A Shimadzu UV visible spectrophotometer equipped with 1cm matched quartz cells was used for all measurements. Every solution was made from scratch using pure water.

 

PREPARATION OF STANDARD STOCK SOLUTIONS:

Methanol was used to create standard tadalafil stock solutions. Methanol was added to a suitable volume of standard stock solution to achieve a concentration of 100 micrograms/mL of tadalafil. These solutions were further diluted in distilled water to provide conventional linearity concentrations for tadalafil in the range of 20–120 micrograms/mL.

 

SAMPLE PREPARATION:

Twenty tablets in all were precisely weighed and ground into a powder in a mortar. A 50mL volumetric flask was filled with precisely weighed amounts of the powdered tablets equal to 50mg. 30 milliliters of methanol were used to dissolve the weighed powder. After that, 50mL of methanol was added, properly mixed, and shaken for ten minutes. To achieve the desired concentration, the solution was diluted with distilled water solvent after passing through Whatman No. 42 filter paper and discarding a few milliliters of the filtrate.

 

Tadalafil working standard solutions were analyzed in order to create calibration curves. Every concentration was examined three times. Spectra of UV absorption were captured. Plotting the calibration curve involved using the Y axis for absorbance and the X axis for concentrations. The equation Y = mx + b, where m is the slope and b is the intercept, expresses the relationship between drug concentration (x) and its related absorbance (y).

 

Table No 2: Calibration Data for Tadalafil

Sr No

Concentration (micro gram/ml)

Absorbance

1

20

0.9

2

40

1.7

3

60

2.6

4

80

3.5

5

100

4.4

6

120

5.4

 

Fig no 1 standarad calibration curve

 

Selection of Wavelength:

The stock solution of concentration 10μg/ml was scanned over the range of 200–400nm and from recorded spectra the wavelength selected was 284nm

 

 

Fig No 2: Uv Spectra for Tadalafil

 

 

Fig no 3-FTIR Spectra for tadalafil

 

No.

Functional group (s)

Characteristic Absorption (s) range (cm-1)

Identified in this study (cm-1)

1

Aromatic C-H stretch

2950-2850

2918.53

2

C=C bond

1700-1500

1427-59

3

N-H stretch

3500-3300

3317.06

4

Benzene C=C Bond

1600-1500

1645.36

5

C=O Stretch

1750-1680

1675.45

METHOD B:

Tadalafil working standard solutions were analyzed in order to create calibration curves. Every concentration was examined three times. absorption of UV light. Spectrum underwent derivatization. Tadalafil's first derivative amplitude values (D1) were measured. Plotting the calibration curve involved taking the concentrations on the X axis and the first derivative values (D1) on the Y axis. The equation Y=mx+b, where m is the slope and b is the intercept, expresses the relationship between drug concentration (x) and its associated first derivative value (D1) value (y).

 

SAMPLE ANALYSIS:

Applicability of the proposed methods for the UV Spectrophotometric estimation Tadalafil was studied by assay of commercial tablets. The results obtained are given in Table no 4

 

RESULT AND DISCUSSION:

Table 3 summarizes the results of the calculations of the optical features, such as absorption maxima and Beer's law limitations, and the regression characteristics, such as slope (b), intercept (a), correlation coefficient (r), and standard error.

 

Table no 3: Optical characteristics

Parameter

UV Spectroscopy

Derivative spectroscopy

Wavelength

284 nm

284 nm

Beer’s law limit

(micro gram/mL)

20-120 micro gram/mL

20-120 micro gram/mL

Slope(m)

0.045

0.3028

Intercept

0.06667

0.1530

(Y = mx + b), where m is slope and b is intercept.

Y=0.045X

 -0.0667

Y=0.3028

+0.1530

Correlation coefficient (r)

0.9991

0.9994

 

Recovery experiments were conducted by adding a known quantity of medication to a pre-analyzed sample, and the percentage recovery was computed in order to examine the precision and repeatability of the suggested approach. Table 4 presents the findings. The obtained results are consistent with the label clam.

 

For the estimation of tadalafil, two quick, easy, and precise UV and first derivative spectroscopic techniques have been developed. Both of these techniques have been effectively used to determine the medication in tablet dose forms. In quality control labs, these might be helpful for routine drug analyses.

 

Table no 4: assay and recovery

Tablet

Lable claim

Amount founded by proposed method

% Amount founded by proposed method

% Recovery by proposed method

cialis

20 mg

19.80 mg

99.10

99.45

 

 

ACKNOWLEDGEMENT:

Authors are thankful to the Department of Pharmaceutical Chemistry, Shri Sureshdada Jain College of Pharmacy Jammer for providing the instrumentation and laboratory facilities.

 

CONCLUSION:

In this study a simple, rapid, sensitive, accurate and precise UV spectrophotometric method for the determination of tadalafil in bulk and pharmaceutical formulation has been developed and validated. It was found that the common excepients present in the formulation did not interfere with the proposed method and can be used for the routine quality control analysis of tadalafil in bulk as well as in tablet formulations In this study a simple, rapid, sensitive, accurate and precise UV spectrophotometric method for the determination of tadalafil in bulk and pharmaceutical formulation has been developed and validated. It was found that the common excepients present in the formulation did not interfere with the proposed method and can be used for the routine quality control analysis of tadalafil in bulk as well as in tablet formulations This work developed and validated a straight forward, quick, sensitive, accurate, and precise UV spectrophotometric method for determining the amount of tadalafil in pharmaceutical formulations and bulk. Tadalafil in bulk and tablet formulations can be routinely analyzed for quality control using the common excepients contained in the formulation, which did not interfere with the suggested procedure.

 

REFERENCES:

1.      Pomerol J M and Rabasseda X. Drugs Today (Barc), 2003; 39: 103-113.

2.      Gupta M, Kovar A and Meibohm B. J Clin Pharmacol. 2005; 45: 987-1003.

3.      Corbin J D and Francis S H. Int J Clin Pract. 2002; 56: 453-459.

4.      Ashak K Shakya, Ahmed N A Abu-Awwad, Tawfiq A Arafat and Munther melhim, J Chromatogr B. 2007; 852: 403-408.

5.      Ramakrishna N V S, Vishwottam K N and Puran M. J Chromatogr B. 2004; 809: 243-249.

6.      Natarajan R, Prabhu C, Rajendran NN. Formulation and evaluation of oral jelly containing tadalafil. Int J Res Pharm Chem. 2014; 4: 479-83.

7.      Mohammad Yunoos, D Gowri Shankar, B Pragathi Kumar. The determination of tadalafil in the bulk and pharmaceutical dosage form. E-J Chem. 2010; 7: 833-6.

8.      Zamirkhan, Amod SP, Atul AS. Estimation of tadalafil in bulk material and in pharmaceutical formulation by using derivative spectroscopy. Int J Spectrosc. 2014: 1-6. https://doi.org/10.1155/2014/392421

 

 

 

Received on 18.12.2024      Revised on 11.01.2025

Accepted on 28.01.2025      Published on 28.02.2025

Available online from March 03, 2025

Asian J. Pharm. Res. 2025; 15(1):6-8.

DOI: 10.52711/2231-5691.2025.00002

©Asian Pharma Press All Right Reserved

 

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.